| 8 January 2020 | Psychosis-associated DNA methylomic variation in Alzheimer’s disease cortex | Pishva, SE; Creese, B; Smith, A; et al. |
| 4 February 2020 | Revisiting criteria for psychosis in Alzheimer’s disease and related dementias- towards better phenotypic classification and biomarker research | Fischer, CE; Ismail, Z; Youakim, JM; et al. |
| 11 February 2020 | The mental and physical health of older adults with a genetic predisposition for autism | Creese, B; Corbett, A; Ballard, C; et al. |
| 15 April 2020 | Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science | Holmes, EA; O'Connor, RC; Perry, VH; et al. |
| 27 July 2020 | Improving mental health and reducing antipsychotic use in people with dementia in care homes: the WHELD research programme including two RCTs | Ballard, C; Orrell, M; Moniz-Cook, E; et al. |
| 2020 | FLAME: A computerized neuropsychological composite for trials in early dementia | Brooker, H; Williams, G; Hampshire, A; et al. |
| 13 April 2020 | Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial | Surr, CA; Holloway, I; Walwyn, REA; et al. |
| 30 July 2020 | Dementia prevention, intervention, and care: 2020 report of the Lancet Commission | Livingston, G; Huntley, J; Sommerlad, A; et al. |
| 2020 | Mild Cognitive Impairment: the Manchester Consensus | Dunne, RA; Aarsland, D; O'Brien, JT; et al. |
| 22 August 2020 | Whole transcriptome in-silico screening implicates cardiovascular and infectious disease in the mechanism of action underlying atypical antipsychotic side-effects | Malekizadeh, Y; Williams, G; Kelson, M; et al. |
